Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile
- PMID: 28463973
- PMCID: PMC5413034
- DOI: 10.1371/journal.pone.0176454
Helicobacter pylori strains from a Nigerian cohort show divergent antibiotic resistance rates and a uniform pathogenicity profile
Abstract
Antibiotic resistance in Helicobacter pylori is a factor preventing its successful eradication. Particularly in developing countries, resistance against commonly used antibiotics is widespread. Here, we present an epidemiological study from Nigeria with 111 isolates. We analyzed the associated disease outcome, and performed a detailed characterization of these isolated strains with respect to their antibiotic susceptibility and their virulence characteristics. Furthermore, statistical analysis was performed on microbiological data as well as patient information and the results of the gastroenterological examination. We found that the variability concerning the production of virulence factors between strains was minimal, with 96.4% of isolates being CagA-positive and 92.8% producing detectable VacA levels. In addition, high frequency of bacterial resistance was observed for metronidazole (99.1%), followed by amoxicillin (33.3%), clarithromycin (14.4%) and tetracycline (4.5%). In conclusion, this study indicated that the infection rate of H. pylori infection within the cohort in the present study was surprisingly low (36.6%). Furthermore, an average gastric pathology was observed by histological grading and bacterial isolates showed a uniform pathogenicity profile while indicating divergent antibiotic resistance rates.
Conflict of interest statement
Figures




Similar articles
-
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].Rev Esp Quimioter. 2006 Mar;19(1):34-8. Rev Esp Quimioter. 2006. PMID: 16688289 Spanish.
-
Analysis of clinical isolates of Helicobacter pylori in Pakistan reveals high degrees of pathogenicity and high frequencies of antibiotic resistance.Helicobacter. 2014 Oct;19(5):387-99. doi: 10.1111/hel.12142. Epub 2014 May 14. Helicobacter. 2014. PMID: 24827414 Free PMC article.
-
Associations between biofilm formation and virulence factors among clinical Helicobacter pylori isolates.Microb Pathog. 2024 Nov;196:106977. doi: 10.1016/j.micpath.2024.106977. Epub 2024 Sep 23. Microb Pathog. 2024. PMID: 39321970
-
Natural small-molecule compounds targeting Helicobacter pylori virulence factors: A promising strategy for overcoming antibiotic resistance.Biochem Biophys Res Commun. 2025 Jul 1;768:151877. doi: 10.1016/j.bbrc.2025.151877. Epub 2025 Apr 23. Biochem Biophys Res Commun. 2025. PMID: 40334425 Review.
-
Molecular biology methods for the characterization of Helicobacter pylori infections and their diagnosis.APMIS. 2004 Nov-Dec;112(11-12):886-97. doi: 10.1111/j.1600-0463.2004.apm11211-1211.x. APMIS. 2004. PMID: 15688524 Review.
Cited by
-
An improved quantitative real-time polymerase chain reaction technology for Helicobacter pylori detection in stomach tissue and its application value in clinical precision testing.BMC Biotechnol. 2020 Jun 22;20(1):33. doi: 10.1186/s12896-020-00624-z. BMC Biotechnol. 2020. PMID: 32571272 Free PMC article.
-
Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data.Biomolecules. 2022 May 11;12(5):691. doi: 10.3390/biom12050691. Biomolecules. 2022. PMID: 35625618 Free PMC article. Review.
-
Detection of Helicobacter pylori and its virulence genes (cagA, dupA, and vacA) among patients with gastroduodenal diseases in Chris Hani Baragwanath Academic Hospital, South Africa.BMC Gastroenterol. 2019 May 14;19(1):73. doi: 10.1186/s12876-019-0986-0. BMC Gastroenterol. 2019. PMID: 31088381 Free PMC article.
-
Helicobacter pylori Infection, Virulence Genes' Distribution and Accompanying Clinical Outcomes: The West Africa Situation.Biomed Res Int. 2019 Dec 10;2019:7312908. doi: 10.1155/2019/7312908. eCollection 2019. Biomed Res Int. 2019. PMID: 31886245 Free PMC article. Review.
-
Current understanding and management of Helicobacter pylori infection: an updated appraisal.F1000Res. 2018 Jun 11;7:F1000 Faculty Rev-721. doi: 10.12688/f1000research.14149.1. eCollection 2018. F1000Res. 2018. PMID: 29946428 Free PMC article. Review.
References
-
- Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clinical microbiology reviews. 2006;19(3):449–90. doi: 10.1128/CMR.00054-05 - DOI - PMC - PubMed
-
- Jimenez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner. PLoS pathogens. 2009;5(12):e1000684 doi: 10.1371/journal.ppat.1000684 - DOI - PMC - PubMed
-
- Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science. 2000;287(5457):1497–500. - PubMed
-
- Fischer W, Puls J, Buhrdorf R, Gebert B, Odenbreit S, Haas R. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation in host cells and induction of interleukin-8. Molecular microbiology. 2001;42(5):1337–48. - PubMed
-
- Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002;295(5555):683–6. doi: 10.1126/science.1067147 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources